IPOL Vaccine
In stock (1000 available)
IPOL® (Poliovirus Vaccine Inactivated) is a prescription vaccine designed to provide active immunization against poliomyelitis (polio) caused by poliovirus Types 1, 2, and 3. It is indicated for infants from 6 weeks of age, children, and adults, making it an established option for individuals who require protection as part of an appropriate immunization plan.
Description
Inactivated Poliovirus Vaccine for Polio Prevention
Three-Strain Polio Protection
IPOL contains inactivated poliovirus representing all three poliovirus types—Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). The vaccine uses purified, concentrated viral antigens that are subsequently inactivated during manufacturing.
This formulation distinguishes IPOL as a dedicated inactivated poliovirus vaccine (IPV) for healthcare professionals seeking a licensed product specifically indicated for polio immunization.
Established Vaccine Formulation
Manufactured by Sanofi Pasteur, IPOL is supplied as a sterile vaccine suspension and is available as a prescription product. FDA records identify IPOL as a licensed biological product, with presentations listed for injection by intramuscular or subcutaneous administration.
Key Features
- Inactivated poliovirus vaccine (IPV)
- Covers poliovirus Types 1, 2, and 3
- Indicated for infants aged 6 weeks and older, children, and adults
- Prescription vaccine for active immunization against poliomyelitis
- Manufactured by Sanofi Pasteur
- Licensed for use in the United States
Important Information
IPOL should be administered by an appropriately qualified healthcare professional according to the current prescribing information and applicable immunization recommendations. Patients or caregivers should discuss vaccination history, allergies, medical conditions, and the appropriate vaccination schedule with their healthcare provider before administration.
For customers searching for IPOL vaccine, inactivated poliovirus vaccine, IPV vaccine, or polio vaccination, IPOL provides an established, FDA-licensed option for active immunization against poliomyelitis.